news
NICE does not recommend esketamine for treatment-resistant depression
Esketamine nasal spray did not receive a positive opinion from NICE due to inadequate comparisons to other therapies and concerns over its cost effectiveness.
List view / Grid view
Depression
Filter the results
news
MHRA alert: missing information on Dr Reddy’s finasteride information leaflet
According to the MHRA, the finasteride 5mg tablets produced by Dr Reddy’s do not contain certain warnings and precautions in the patient information leaflets.
news
Psilocybin study shows positive results in healthy volunteers
In a new study, COMP360 (psilocybin) was well tolerated in healthy volunteers which support further investigation of a simultaneous 1:1 therapeutic administration design.
news
No association found between trazodone and reduced risk of dementia
The antidepressant drug, trazodone, taken for anxiety and depression, has been found not to be linked to a reduced risk of dementia...
news
Benzodiazepines could decrease mortality in congestive heart failure
Researchers have suggested that benzodiazepines should be the first course of treatment for those with cardiovascular disease and anxiety...
news
Antidepressant use may be linked to increased risk of weight gain
Prolonged use of antidepressants may lead to increased risk of weight gain...
news
Benzodiazepines can help depression
New research points to the important role that benzodiazepines may have in depression...
news
Study finds antidepressants to be more effective than placebos
Major international study – comprising largest amount of unpublished data to date – has found that antidepressants are more effective than placebos for short-term treatment of acute depression in adults.
news
Researchers use data mining to expedite effective prescriptions for depression patients
In a bid to maximise the effectiveness of treatment for patients, doctors have been using predictive models. New research finds that accessing data from electronic medical records could greatly benefit this practice.
news
FDA approves pill that tracks if patients have ingested their medication
The FDA has approved the first drug in the U.S. with a digital ingestion tracking system that records that the medication was taken...
news
Ketamine may help treat migraine pain unresponsive to other therapies
Ketamine, a medication commonly used for pain relief and increasingly used for depression, may help alleviate migraine pain...
news
Amorsa to collaborate with J&J on treatment-resistant depression therapy
5 January 2017 | By Niamh Marriott, Digital Editor
Amorsa has announced a research, option and license agreement with Janssen to develop and commercialise a novel small molecule drug candidate for depression...
news
Novartis’ global study shows 57% of psoriasis patients didn’t reach clear skin treatment goal
3 October 2016 | By Niamh Louise Marriott, Digital Content Producer
People with the autoimmune disease, psoriasis, also report that they face discrimination, humiliation, and mental illness...
news
FDA grants breakthrough therapy designation for depression drug
16 August 2016 | By Janssen
Following succesful phase II trials, the FDA have granted a Breakthrough Therapy Designation for esketamine, an investigational antidepressant medication...
news
Depression symptoms in remission after correcting metabolic deficiencies
12 August 2016 | By Niamh Louise Marriott, Digital Content Producer
Searching for answers through a series of biochemical tests, the scientists discovered that the patient had a cerebrospinal fluid deficiency in biopterin, a protein involved in the synthesis of several brain signalling chemicals called neurotransmitters. After receiving an analogue of biopterin to correct the deficiency, the patient's depression symptoms largely…